Rejuvesol

Basic Information

Product Name

Rejuvesol

FDA Product Code

23731-7000

Regulatory Information

NDC Product Code

23731-7000

Application Number

BN950522

Marketing Category

C73594

Effective Date

February 14, 2023

Territorial Authority

USA

FDA Title

rejuvesol red blood cell processing solution

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Version Number

Active Ingredients

SODIUM PYRUVATE

Quantity: 0.55 g in 50 mL

Code: POD38AIF08

Class Code: ACTIB

SODIUM PHOSPHATE, DIBASIC

Quantity: 0.73 g in 50 mL

Code: GR686LBA74

Class Code: ACTIB

INOSINE

Quantity: 1.34 g in 50 mL

Code: 5A614L51CT

Class Code: ACTIB

ADENINE

Quantity: 0.034 g in 50 mL

Code: JAC85A2161

Class Code: ACTIB

SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE

Quantity: 0.311 g in 50 mL

Code: 593YOG76RN

Class Code: ACTIB

Active Moieties

PYRUVIC ACID

Code: 8558G7RUTR

INOSINE

Code: 5A614L51CT

ADENINE

Code: JAC85A2161

SODIUM CATION

Code: LYR4M0NH37

Basic Information

Regulatory Information

Company Information

Active Ingredients

Active Moieties

PYRUVIC ACID

INOSINE

ADENINE

SODIUM CATION